Cargando…

Intravenous edaravone treatment in ALS and survival: An exploratory, retrospective, administrative claims analysis

BACKGROUND: We aimed to evaluate overall survival in US patients with amyotrophic lateral sclerosis (ALS) treated with intravenous (IV) edaravone compared with those not treated with IV edaravone in a real-world setting. METHODS: This exploratory retrospective comparative effectiveness observational...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brooks, Benjamin Rix, Berry, James D., Ciepielewska, Malgorzata, Liu, Ying, Zambrano, Gustavo Suarez, Zhang, Jeffrey, Hagan, Melissa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9358426/ https://www.ncbi.nlm.nih.gov/pubmed/35958519 http://dx.doi.org/10.1016/j.eclinm.2022.101590

Ejemplares similares

Quantifying the Value of Introducing an Oral Drug Delivery Option for Edaravone: A Review of Analyses Evaluating the Economic Impact of Oral versus Intravenous Formulations
por: Ronquest, Naoko A, et al.
Publicado: (2022)

Analysis of the US Safety Data for Edaravone (Radicava(®)) From the Third Year After Launch
por: Genge, Angela, et al.
Publicado: (2022)

Slowing the loss of physical function in amyotrophic lateral sclerosis with edaravone: Post hoc analysis of ALSFRS‐R item scores in pivotal study MCI186‐19
por: Brooks, Benjamin Rix, et al.
Publicado: (2021)

Edaravone efficacy in amyotrophic lateral sclerosis with reduced forced vital capacity: Post-hoc analysis of Study 19 (MCI186-19) [clinical trial NCT01492686]
por: Brooks, Benjamin Rix, et al.
Publicado: (2022)

Radicava/Edaravone Findings in Biomarkers From Amyotrophic Lateral Sclerosis (REFINE-ALS): Protocol and Study Design
por: Berry, James, et al.
Publicado: (2021)

Bioequivalence Study of Oral Suspension and Intravenous Formulation of Edaravone in Healthy Adult Subjects
por: Shimizu, Hidetoshi, et al.
Publicado: (2021)

Neuroprotective effects of edaravone-administration on 6-OHDA-treated dopaminergic neurons
por: Ji Yuan, Wen, et al.
Publicado: (2008)

Stereotactic Administration of Edaravone Ameliorates Collagenase‐Induced Intracerebral Hemorrhage in Rat
por: Zhang, Yan, et al.
Publicado: (2016)

Effect of edaravone therapy in Korean amyotrophic lateral sclerosis (ALS) patients
por: Park, Jin-Mo, et al.
Publicado: (2019)

New Adamantane-Containing Edaravone Conjugates as Potential Neuroprotective Agents for ALS Treatments
por: Lapshina, Maria A., et al.
Publicado: (2023)

Long-term effects of edaravone on survival of patients with amyotrophic lateral sclerosis
por: Okada, Masamitsu, et al.
Publicado: (2018)

Edaravone: a baby in the bathwater?
por: Ludolph, Albert
Publicado: (2017)

Investigating Edaravone Use for Management of Amyotrophic Lateral Sclerosis (ALS): A Narrative Review
por: Neupane, Purushottam, et al.
Publicado: (2023)

Protective Effects of Edaravone in Adult Rats with Surgery and Lipopolysaccharide Administration-Induced Cognitive Function Impairment
por: Wang, Peiqi, et al.
Publicado: (2016)

Phase I Clinical Study of Edaravone in Healthy Chinese Volunteers: Safety and Pharmacokinetics of Single or Multiple Intravenous Infusions
por: Li, Hao, et al.
Publicado: (2012)

Effects of intravenous thrombolysis with alteplase combined with edaravone on cerebral hemodynamics and T lymphocyte level in patients with acute cerebral infarction
por: Li, Xiu-Xiu, et al.
Publicado: (2020)

Role of edaravone in managemant of septic peritonitis
por: Elbaradey, Ghada Fouad, et al.
Publicado: (2016)

Concordance between administrative claims and registry data for identifying metastasis to the bone: an exploratory analysis in prostate cancer
por: Onukwugha, Eberechukwu, et al.
Publicado: (2014)

Cost-effectiveness of edaravone dexborneol versus edaravone for the treatment of acute ischemic stroke in China: Based on the TASTE study
por: Shi, Fenghao, et al.
Publicado: (2022)

Edaravone combined with Shuxuening versus edaravone alone in the treatment of acute cerebral infarction: A systematic review and meta-analysis
por: Li, Liang-Da, et al.
Publicado: (2023)

4-Cl-edaravone and (E)-2-chloro-3-[(E)-phenyldiazenyl]-2-butenoic acid are the specific reaction products of edaravone with hypochlorite
por: Amekura, Sakiko, et al.
Publicado: (2020)

Survival and comorbidities in lung cancer patients: Evidence from administrative claims data in Germany
por: HERNANDEZ, DIEGO, et al.
Publicado: (2023)

A radical scavenger edaravone and oligodendrocyte protection/regeneration
por: Takase, Hajime, et al.
Publicado: (2018)

Is Edaravone the Future of Free Radical Scavenging in Inflammatory States?
por: Nair, Abhijit S.
Publicado: (2017)

Effect of edaravone in diabetes mellitus-induced nephropathy in rats
por: Varatharajan, Rajavel, et al.
Publicado: (2016)

Edaravone administration and its potential association with a new clinical syndrome in cerebral infarction patients: Three case reports
por: Yang, Liu, et al.
Publicado: (2023)

Is Free Testosterone Concentration a Prognostic Factor of Survival in Chronic Renal Failure (CRF)?
por: Niemczyk, Stanisław, et al.
Publicado: (2015)

Density Functional Theory (DFT) Study of Edaravone Derivatives as Antioxidants
por: Borges, Rosivaldo S., et al.
Publicado: (2012)

Inhibitory Effects of Edaravone in β-Amyloid-Induced Neurotoxicity in Rats
por: He, Feng, et al.
Publicado: (2014)

Stabilizers of edaravone aqueous solution and their action mechanisms. 2. Glutathione
por: Tanaka, Masahiko, et al.
Publicado: (2017)

Edaravone and cyclosporine A as neuroprotective agents for acute ischemic stroke
por: Matsumoto, Shohei, et al.
Publicado: (2018)

Ethnical Disparities in Response to Edaravone in Patients With Amyotrophic Lateral Sclerosis
por: Jayasinghe, Maleesha, et al.
Publicado: (2022)

Antiviral Effect and Mechanism of Edaravone against Grouper Iridovirus Infection
por: Kuang, Jihui, et al.
Publicado: (2023)

An Algorithm for the Identification of Undiagnosed COPD Cases Using Administrative Claims Data
por: Mapel, Douglas W., et al.
Publicado: (2006)

Edaravone Inhibits the Production of Reactive Oxygen Species in Phagocytosis- and PKC-Stimulated Granulocytes from Multiple Sclerosis Patients Edaravone Modulate Oxidative Stress in Multiple Sclerosis
por: Villar-Delfino, Pedro Henrique, et al.
Publicado: (2022)

The Intravenous Administration of Salvarsan
por: Gibson, H. R. B.
Publicado: (1911)

Recurrent severe hypophosphatemia following intravenous iron administration
por: Nataatmadja, Melissa Stephanie, et al.
Publicado: (2020)

Linking individual medicare health claims data with work-life claims and other administrative data
por: Mokyr Horner, Elizabeth, et al.
Publicado: (2015)

Development of a machine learning algorithm based on administrative claims data for identification of ED anaphylaxis patient visits
por: Campbell, Ronna L., et al.
Publicado: (2022)

Edaravone Guards Dopamine Neurons in a Rotenone Model for Parkinson's Disease
por: Xiong, Nian, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_drfg33cmsvrt0q9ggqk1s54hhu